Want to see IN:VISHNU full AI Analyst Report?
Vishnu Chemicals Limited (VISHNU) AI Stock Analysis
Vishnu Chemicals Limited
(NSE:VISHNU)
The overall score reflects a combination of strong technical momentum and an improved financial profile, with the stock trading well above key moving averages and showing positive trend indicators, while revenue and profit have grown significantly and leverage is much lower than in the past. These strengths are tempered by sustained negative free cash flow and rising debt that heighten cash-flow risk, as well as a valuation that assumes continued growth and is supported but not fully offset by the relatively high dividend yield.
Vishnu Chemicals Limited (VISHNU) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 36.49B
- Dividend Yield
- 0.06%
- Average Volume (3M)
- 6,782
- Price to Earnings (P/E)
- 24.3
- Beta (1Y)
- 0.72
- Revenue Growth
- 16.61%
- EPS Growth
- 15.18%
- Country
- India
- Employees
- 464
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Vishnu Chemicals Limited Business Overview & Revenue Model
Company Description
Founded in 1989 and headquartered in Hyderabad, India, Vishnu Chemicals Limited specializes in the manufacturing and global distribution of chromium and barium compounds. The company's extensive product line features various chrome-based chemicals, i...
How the Company Makes Money
Vishnu Chemicals makes money primarily by manufacturing and selling chromium-based specialty chemicals to industrial customers. Revenue is generated through (i) sales of finished chemical products (notably chromium chemicals such as sodium dichromate...
Vishnu Chemicals Limited Financial Statement Overview
Summary
Strong multi-year revenue and profit growth plus a healthier balance sheet support the score, but persistent weak operating cash flow and three years of materially negative free cash flow, alongside rising debt, introduce meaningful cash-flow risk.
Income Statement
76PositiveBalance Sheet
82Very PositiveCash Flow
38Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.94B | 16.10B | 14.47B | 12.09B | 13.88B | 10.66B |
| Gross Profit | 4.15B | 3.99B | 3.58B | 2.93B | 4.93B | 3.86B |
| EBITDA | 2.68B | 2.52B | 2.44B | 2.05B | 2.44B | 1.60B |
| Net Income | 1.50B | 1.42B | 1.27B | 1.01B | 1.37B | 813.93M |
Balance Sheet | ||||||
| Total Assets | 0 | 20.88B | 16.34B | 13.25B | 10.51B | 9.15B |
| Cash, Cash Equivalents and Short-Term Investments | 1.00B | 81.03M | 817.44M | 617.07M | 20.93M | 27.99M |
| Total Debt | 0 | 5.27B | 3.42B | 3.19B | 3.79B | 3.65B |
| Total Liabilities | -10.75B | 10.13B | 7.07B | 6.24B | 6.37B | 6.38B |
| Stockholders Equity | 10.75B | 10.69B | 9.27B | 7.01B | 4.14B | 2.77B |
Cash Flow | ||||||
| Free Cash Flow | 85.24M | -1.64B | -263.28M | -528.47M | 168.85M | 64.28M |
| Operating Cash Flow | 910.85M | 933.10M | 615.23M | 674.98M | 1.34B | 897.27M |
| Investing Cash Flow | -1.42B | -2.71B | -1.07B | -1.54B | -1.18B | -811.50M |
| Financing Cash Flow | 543.59M | 1.83B | 462.23M | 881.28M | -155.73M | -85.66M |
Vishnu Chemicals Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VISHNU, the sentiment is Negative. The current price of 541.90 is below the 20-day moving average (MA) of 619.81, below the 50-day MA of 657.38, and below the 200-day MA of 586.44, indicating a bearish trend. The MACD of -31.41 indicates Positive momentum. The RSI at 25.51 is Positive, neither overbought nor oversold. The STOCH value of 17.55 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VISHNU.
Vishnu Chemicals Limited Peers Comparison
Overall Rating
- IN:VISHNU71Outperform
IN:FCL68Neutral
IN:ROSSARI65Neutral
IN:TATVA55Neutral
IN:LXCHEM46Neutral
IN:NEOGEN46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:VISHNU | 71Outperform | INR 36.48B | 24.32 | ― | 0.06% | 16.61% | 15.18% |
| IN:FCL | 68Neutral | INR 56.58B | 40.33 | ― | 0.27% | 91.44% | 19.67% |
| IN:ROSSARI | 65Neutral | INR 22.12B | 14.48 | ― | 0.13% | 19.76% | 11.74% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:TATVA | 55Neutral | INR 38.49B | 61.11 | ― | 0.12% | 49.69% | 254.75% |
| IN:LXCHEM | 46Neutral | INR 42.47B | 33.72 | ― | 0.20% | 5.47% | 24.88% |
| IN:NEOGEN | 46Neutral | INR 65.47B | 163.88 | ― | 0.05% | 18.00% | 3.85% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:VISHNU | Vishnu Chemicals Limited | 541.90 | 17.85 | 3.41% | |
| IN:FCL | Fineotex Chemical Limited | 48.59 | 16.55 | 51.67% | |
| IN:LXCHEM | Laxmi Organic Industries Ltd. | 152.80 | -43.86 | -22.30% | |
| IN:NEOGEN | Neogen Chemicals Ltd. | 2179.35 | 717.56 | 49.09% | |
| IN:ROSSARI | Rossari Biotech Ltd | 399.25 | -242.58 | -37.79% | |
| IN:TATVA | Tatva Chintan Pharma Chem Limited | 1645.45 | 235.40 | 16.69% |
Vishnu Chemicals Limited Corporate Events
Vishnu Chemicals Corrects EPS Typo Without Changing Underlying Financials
Vishnu Chemicals Limited has issued a corrigendum after identifying a typographical error in the Earnings Per Share figures reported in its unaudited consolidated financial results for the quarter and half year ended 30 September 2026. The company cl...
Vishnu Chemicals Schedules Mumbai Investor Meetings, Affirms Compliance with SEBI Norms
Vishnu Chemicals Limited, a listed player in the chemicals sector on BSE and NSE under the symbol VISHNU, continues to position itself as a transparent and compliant participant in India’s capital markets. The company’s ongoing engagement...
Vishnu Chemicals Schedules Virtual Analyst and Investor Meetings
Vishnu Chemicals Limited has scheduled virtual one-on-one meetings with analysts and institutional investors on August 19 and 20, 2026, starting at 4.00 PM IST on both days. These engagements form part of its ongoing investor relations efforts and ar...
Vishnu Chemicals Sets August 28 Date for Virtual 33rd AGM
Vishnu Chemicals Limited has announced that its 33rd Annual General Meeting will be held on August 28, 2026, at 11:00 a.m. IST via video conferencing or other audio-visual means. The company has published statutory notices about the AGM and related m...
Vishnu Chemicals Publishes Q1FY27 Investor Presentation
Vishnu Chemicals Limited has released an investor presentation covering its financial results for the first quarter of FY27, ended June 30, 2026. The presentation, filed with both the BSE and NSE and made available on the company’s website, is...
Vishnu Chemicals Publishes Q1 FY27 Results in Leading Dailies
Vishnu Chemicals Limited has notified the stock exchanges that it has published newspaper advertisements detailing its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The results were carried in The...
Vishnu Chemicals Delivers 25% Revenue Growth in Q1FY27 on Broad-Based Demand
Vishnu Chemicals reported a strong start to FY27, posting consolidated operating revenue of ₹433.4 crore for Q1FY27, up 24.9% year-on-year, with EBITDA rising 17.5% and profit after tax increasing 23.0%. Despite a slight sequential moderation d...
Vishnu Chemicals Posts Strong Q1 FY27 Results With Higher Revenue and Profit
Vishnu Chemicals Limited’s board has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, marking a strong start to the fiscal year. The disclosure, filed with both BSE and NSE and posted on...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026